Open AccessResistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC β-lactamase of a Serratia marcescens clinical isolate
Author(s) -
Nadia Hidri,
Guilène Barnaud,
Dominique Decré,
Claude Cerceau,
V. Lalande,
J.C. Petit,
Roger Labia,
Guillaume Arlet
Publication year - 2005
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dki025
Subject(s) - ceftazidime , serratia marcescens , microbiology and biotechnology , biology , mutagenesis , gene , bacteria , escherichia coli , genetics , mutation , pseudomonas aeruginosa
The aim of this study was to characterize the ampC beta-lactamase gene of a clinical isolate of Serratia marcescens resistant to ceftazidime.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom